Org.nr 812 197 142 2022 → 2023 Year-over-year analysis

4X4 MEDICINE AS: årsregnskap 2023 vs 2022

Weaker earnings

registry 2024-03-09; journal 2024 322493

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2023 with 2022 for 4X4 MEDICINE AS. Revenue 694.9k NOK → 679.3k NOK (-2.2%). Net result +2.18m NOK → +171.8k NOK. Equity 1.65m NOK → 782.4k NOK.

On the constructive side: cash rose; owners injected capital. Pressures included: revenue fell; operating result weakened; net result weakened.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for 4X4 MEDICINE AS.

Scorecard

Revenue
694.9k NOK 679.3k NOK
-2.2%
Operating result
+257.4k NOK +201.6k NOK
-21.7%
Net result
+2.18m NOK +171.8k NOK
-92.1%
Equity
1.65m NOK 782.4k NOK
-52.6%
Cash
101.6k NOK 1.13m NOK
+1012.1%
Total assets
2.64m NOK 1.48m NOK
-44.1%

What improved

  • ↑

    Cash rose

    Bank deposits 101.6k NOK → 1.13m NOK (+1012.1% YoY). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 390.4k NOK → 431.9k NOK (+41.5k NOK). Reported fact

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 694.9k NOK to 679.3k NOK (-2.2% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result +257.4k NOK → +201.6k NOK (op. margin 37.0% → 29.7%). Calculated

  • ↓

    Net result weakened

    Net result +2.18m NOK → +171.8k NOK (net margin 313.5% → 25.3%). Calculated

  • ↓

    Equity eroded

    Book equity 1.65m NOK → 782.4k NOK (equity ratio 62.6% → 53.0%). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 583.3k NOK → 291.7k NOK. Reported fact